Guidelines of the French Speaking Society for Chest Medicine for management of malignant pleural mesothelioma
- 1 June 2007
- journal article
- review article
- Published by Elsevier in Respiratory Medicine
- Vol. 101 (6) , 1265-1276
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Needle-track metastases and prophylactic radiotherapy for mesotheliomaRespiratory Medicine, 2006
- Malignant mesothelioma: A minor issue about gender ratio and a major issue about regulatory policyRespiratory Medicine, 2006
- Short-Term Treatment-Related Symptoms and Quality of Life: Results From an International Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup StudyJournal of Clinical Oncology, 2006
- A randomised trial in malignant mesothelioma (M) of early (E) versus delayed (D) chemotherapy in symptomatically stable patients: the MED trialAnnals of Oncology, 2005
- Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of CanadaJournal of Clinical Oncology, 2005
- Malignant mesotheliomaThe Lancet, 2005
- Malignant pleural mesotheliomaCurrent Problems in Cancer, 2004
- The Immunohistochemical Diagnosis of MesotheliomaAmerican Journal of Surgical Pathology, 2003
- Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2003